PL366744A1 - Single dose aromatase inhibitor for treating infertility - Google Patents

Single dose aromatase inhibitor for treating infertility

Info

Publication number
PL366744A1
PL366744A1 PL02366744A PL36674402A PL366744A1 PL 366744 A1 PL366744 A1 PL 366744A1 PL 02366744 A PL02366744 A PL 02366744A PL 36674402 A PL36674402 A PL 36674402A PL 366744 A1 PL366744 A1 PL 366744A1
Authority
PL
Poland
Prior art keywords
single dose
aromatase inhibitor
treating infertility
dose aromatase
infertility
Prior art date
Application number
PL02366744A
Other languages
English (en)
Polish (pl)
Inventor
Robert F. Casper
Mohamed F.M. Mitwally
Original Assignee
Ares Trading S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading S.A. filed Critical Ares Trading S.A.
Publication of PL366744A1 publication Critical patent/PL366744A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02366744A 2001-04-17 2002-04-17 Single dose aromatase inhibitor for treating infertility PL366744A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28428201P 2001-04-17 2001-04-17

Publications (1)

Publication Number Publication Date
PL366744A1 true PL366744A1 (en) 2005-02-07

Family

ID=23089583

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02366744A PL366744A1 (en) 2001-04-17 2002-04-17 Single dose aromatase inhibitor for treating infertility

Country Status (32)

Country Link
US (1) US8008333B2 (enExample)
EP (1) EP1383578B1 (enExample)
JP (1) JP2004529924A (enExample)
KR (1) KR20040025916A (enExample)
CN (1) CN1551789A (enExample)
AR (1) AR034036A1 (enExample)
AT (1) ATE409066T1 (enExample)
AU (1) AU2002249043B2 (enExample)
BG (1) BG108323A (enExample)
BR (1) BR0208920A (enExample)
CA (1) CA2444980C (enExample)
CY (1) CY1108648T1 (enExample)
CZ (1) CZ20033107A3 (enExample)
DE (1) DE60229047D1 (enExample)
DK (1) DK1383578T3 (enExample)
EA (1) EA011310B1 (enExample)
EE (1) EE200300505A (enExample)
ES (1) ES2311599T3 (enExample)
HR (1) HRP20030839A2 (enExample)
HU (1) HUP0304003A2 (enExample)
IL (1) IL158396A0 (enExample)
MX (1) MXPA03009447A (enExample)
NO (1) NO20034246L (enExample)
NZ (1) NZ552873A (enExample)
PL (1) PL366744A1 (enExample)
PT (1) PT1383578E (enExample)
SI (1) SI1383578T1 (enExample)
SK (1) SK14242003A3 (enExample)
UA (1) UA82648C2 (enExample)
WO (1) WO2002083241A1 (enExample)
YU (1) YU81203A (enExample)
ZA (1) ZA200307516B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050077045A (ko) * 2002-07-02 2005-07-29 파마시아 앤드 업존 캄파니 엘엘씨 엑스메스탄을 사용한 불임 치료법
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
CA2619503A1 (en) * 2005-06-28 2007-01-04 Robert F. Casper Aromatase inhibitors for emergency contraception
WO2007081980A2 (en) * 2006-01-10 2007-07-19 Diobex, Inc. Methods and compositions for treating prostate cancer
BR112012029392A2 (pt) * 2010-05-20 2017-07-11 Univ Saskatchewan uso d einibidores de aromatase para a sincronização da ovulação, indução da superovulação ou ovulação dupla e melhora da geminação e fertilidade em um mamífero
BR112015026298A8 (pt) 2013-04-19 2019-12-24 Univ Saskatchewan veículo de dispensação para a dispensação de um inibidor da aromatase
US20160022644A1 (en) * 2014-07-22 2016-01-28 Tsu-I Catherine Wang Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4845227A (en) * 1984-06-18 1989-07-04 Eli Lilly And Company Aromatase inhibitors from azoles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
GB8726505D0 (en) * 1987-11-12 1987-12-16 Ici Plc Naphtho(2 1-b)furan derivatives
DE4330237C2 (de) 1993-09-02 1995-11-30 Schering Ag 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
WO1997040846A1 (en) * 1996-04-30 1997-11-06 Takeda Chemical Industries, Ltd. COMBINED USE OF GnRH AGONIST AND ANTAGONIST
DE19622457A1 (de) 1996-05-24 1997-11-27 Schering Ag 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
IL158396A0 (en) 2004-05-12
JP2004529924A (ja) 2004-09-30
NO20034246D0 (no) 2003-09-23
SI1383578T1 (sl) 2008-12-31
DE60229047D1 (de) 2008-11-06
KR20040025916A (ko) 2004-03-26
WO2002083241A1 (en) 2002-10-24
MXPA03009447A (es) 2004-05-24
BG108323A (bg) 2004-12-30
EA011310B1 (ru) 2009-02-27
BR0208920A (pt) 2004-04-20
EP1383578A1 (en) 2004-01-28
AR034036A1 (es) 2004-01-21
EP1383578B1 (en) 2008-09-24
US8008333B2 (en) 2011-08-30
PT1383578E (pt) 2008-10-08
CY1108648T1 (el) 2014-04-09
ATE409066T1 (de) 2008-10-15
CA2444980C (en) 2010-08-17
NZ552873A (en) 2008-05-30
CN1551789A (zh) 2004-12-01
ZA200307516B (en) 2004-09-27
CZ20033107A3 (en) 2004-03-17
CA2444980A1 (en) 2002-10-24
EE200300505A (et) 2004-02-16
NO20034246L (no) 2003-12-15
HUP0304003A2 (hu) 2004-04-28
YU81203A (sh) 2006-05-25
UA82648C2 (uk) 2008-05-12
ES2311599T3 (es) 2009-02-16
EA200301128A1 (ru) 2004-04-29
AU2002249043B2 (en) 2008-01-10
HRP20030839A2 (en) 2005-08-31
US20040171660A1 (en) 2004-09-02
DK1383578T3 (da) 2008-11-03
SK14242003A3 (sk) 2004-03-02

Similar Documents

Publication Publication Date Title
IL233205B (en) Substances for the treatment or prevention of pre-eclampsia
IL159376A (en) Apparatus for acne treatment
GB0316313D0 (en) Methods for specifically inhibiting histone deacetylase-4
EP1465968A4 (en) METHODS OF TREATING DISTILLATE DEODORIZER
EP1414492A4 (en) METHOD FOR THE TREATMENT OF MULTIPLE MYELOMA
EP1581234A4 (en) METHODS FOR TREATING MIGRAINE
PT1383578E (pt) Inibidor da aromatase em dose única para tratamento da infertilidade
IL144900A0 (en) Method for treating primary insomnia
ZA200306122B (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment.
IL150837A0 (en) Use of fsh for treating infertility
PT1400522E (pt) Compostos para tratar a impotência
IL158395A0 (en) Aromatase inhibitor for use in reproduction
IL156729A0 (en) The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment
AU2001252065A1 (en) Multiple dose aromatase inhibitor for treating infertility
GB0125594D0 (en) Inhibitors for inactivating allergens
AU2002250752A1 (en) Aromatase inhibitors for treating infertility
AU2003251208A8 (en) Apparatus for treating strip-shaped parts
IL160703A0 (en) Method for treating coumarin-induced hemorrhage
EP1549327A4 (en) COMPOSITION FOR THE TREATMENT OF HEMORROIDS
GB0123063D0 (en) Compositions for therapy
CZ20011275A3 (cs) AFB1 - Cytostatikum na léčbu primárního hepatoblastomu
GB0102559D0 (en) Treatment for angiogenesis-dependant condition
GB0121073D0 (en) Inhibitors of complement activation
IL145144A0 (en) Ointment for treating pains
AU2002259331A1 (en) Apparatus for protecting tissue from radiotherapy

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)